How does gastrointestinal inflammation causally contribute to alpha-synuclein pathology and dopaminergic neuronal loss?

neuroinflammation open
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
—
Novelty
—
Mechanistic
—
Druggability
—
Priority
86%
Importance
89%
Tractability
82%
Market price
50%

Description

While the abstract establishes a bidirectional link between GI inflammation and neurodegeneration, the specific causal mechanisms connecting peripheral gut inflammation to the hallmark pathological features of Parkinson’s disease are not mechanistically defined. This knowledge gap limits the development of anti-inflammatory therapeutic strategies.

Gap type: unexplained_observation Source paper: The gut-brain axis in Parkinson’s disease. (2024, Revue neurologique, PMID:38129277)

Resolution criteria

[“Fecal microbiota transplantation from PD patients vs healthy controls into germ-free alpha-synuclein overexpression mice accelerates alpha-synuclein pathology in gut and brain”, “GI inflammation induction (TNBS colitis) in alpha-synuclein mice causes >=40% increase in colonic p-synuclein aggregation vs controls”, “Vagalotomy or pharmacologic blockade of alpha-synuclein intestinal aggregation prevents gut-to-brain propagation”, “Metabolomics of gut-brain axis in inflamed vs non-inflamed conditions identifies 3-5 pro-aggregation metabolites that cross BBB”]